1 in 4 companies say they are considering covering weight-loss drug costsEmployers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.
Not Everyone Loses Weight on OzempicNot all patients experience substantial weight loss with GLP-1 drugs, showcasing the variability in response to anti-obesity medications.
1 in 4 companies say they are considering covering weight-loss drug costsEmployers are cautiously considering covering anti-obesity medications despite significant cost concerns and varying interest based on company size.
Not Everyone Loses Weight on OzempicNot all patients experience substantial weight loss with GLP-1 drugs, showcasing the variability in response to anti-obesity medications.
Weight-loss drug shortages have patients stressed over missing dosesPatients struggle to access anti-obesity medications due to shortages, impacting progress and causing anxiety.
Here's What Americans Think of Weight Loss DrugsAbout 75% of Americans recognize weight loss drugs like Ozempic, Wegovy, and others.Survey shows 53% see anti-obesity drugs as good options, while 62% don't view them suitable for those without weight-related health conditions.
How Research is Changing the Conversation about Obesity - News CenterAnti-obesity medications are gaining attention but face access challenges like insurance coverage and stigma.Research led by Feinberg faculty, such as Dr. Robert Kushner, shows promising results for medications like semaglutide in weight loss treatment.
Confessions of an Ozempic-TakerThe chronicler of addictions, Johann Hari, shares his own struggle with willpower and shame.